[Federal Register Volume 62, Number 204 (Wednesday, October 22, 1997)]
[Notices]
[Page 54857]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-27897]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on September 10, 1997, Nycomed, 
Inc., 33 Riverside Avenue, Rensselaer, New York 12144, made application 
to the Drug Enforcement Administration (DEA) for registration as a bulk 
manufacturer of meperidine (9230) a basic class of controlled substance 
listed in Schedule II.
    The firm plans to manufacture bulk product for distribution to its 
customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than December 22, 1997.

    Dated: October 3, 1997.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 97-27897 Filed 10-21-97; 8:45 am]
BILLING CODE 4410-09-M